SCHEMBL29960809

SCHEMBL29960809

OCC1CCCOc2cscc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29960767 0.82
SCHEMBL29961280 0.80 TAAR1 (0.42)
Hydrochloric Acid SCHEMBL29960666 0.78 ADRA2A (0.33)
SCHEMBL7145240 0.78 ITGB2 (0.39)
SCHEMBL29960786 0.77
Hydrochloric Acid SCHEMBL29960611 0.71 ADRA2A (0.31)
Hydrochloric Acid SCHEMBL29960775 0.68 TAAR1 (0.43)
SCHEMBL29961247 0.67 ITGB2 (0.41)
SCHEMBL3585379 0.67 ITGB2 (0.41)
SCHEMBL3396627 0.66 ITGB2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed